Synairgen welcomes Amanda Radford to its Board as Independent Director

– UK, Southampton –  Synairgen plc (LON: SNG), the respiratory company developing SNG001, an investigational formulation for inhalation containing the broad-spectrum antiviral protein interferon beta, today announced the appointment of Amanda Radford FCA to the Board as an Independent Non-Executive Director.…